Acta Med. 2007, 50: 113-118
Addition of Rituximab Significantly Improves Outcomes in Patients with Diffuse Large B-cell Lymphoma – a Single-center, Retrospective Study
Individual author index pages
- David Belada
- Lukáš Smolej
- Monika Hrudková
- Pavla Štěpánková
- Alice Sýkorová
- Pavel Žák
- Jiří Bukač
- Jaroslav Malý
Other articles of these authors
-
FIFTEEN YEARS OF SINGLE CENTER EXPERIENCE WITH STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA: A RETROSPECTIVE ANALYSIS
Jakub Radocha, Vladimír Maisnar, Alžběta Zavřelová, Melanie Cermanová, Miriam Lánská, Miloslav Kmoníček, Ladislav Jebavý, Milan Bláha, Jaroslav Malý, Pavel Žák
2013, Vol. 56, Issue 1, pp. 9-13 -
ASPIRIN RESISTANCE IN NEUROVASCULAR DISEASES
Martin Vališ, Dagmar Krajíčková, Jaroslav Malý, Radovan Malý, Ilona Fátorová, Oldřich Vyšata, Roman Herzig
2014, Vol. 57, Issue 4, pp. 157-161 -
CASE 2–2012: a 57-Year-Old Woman with Post-Transplant Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation for Primary Myelofibrosis
Milan Košťál, Pavel Žák, Eva Vejražková, Melánie Cermanová, Petra Bělohlávková, Alžběta Zavřelová, Filip Vrbacký, Tomáš Rozkoš, Markéta Nová
2012, Vol. 55, Issue 3, pp. 142-145 -
CASE 3-2011: Invasive Mucormycosis (Zygomycosis) after Bone Marrow Transplantation in a 26-Year-Old Man with Relapsing Acute Myeloid Leukaemia
Alžběta Zavřelová, Adéla Matějková, Markéta Nová, Petr Hoffmann, Vladimír Buchta, Pavel Žák
2011, Vol. 54, Issue 4, pp. 163-166 -
How I Treat Elderly or Comorbid Patients with Chronic Lymphocytic Leukemia
Lukáš Smolej
2010, Vol. 53, Issue 4, pp. 213-220 -
Improvement of Anaemia in Patients with Primary Myelofibrosis by Low-Dose Thalidomide and Prednisone
Petra Bělohlávková, Vladimír Maisnar, Jaroslava Voglová, Tomáš Buchler, Pavel Žák
2016, Vol. 59, Issue 2, pp. 50-53 -
Case 1-2009: A 65-Year-Old Woman with Three Months’ History of Progressive Dyspnea and Recurrent Episodes of Collapse
Pavel Žák, Helena Hornychová, Alena Štrasová, Jaroslava Bednářová
2009, Vol. 52, Issue 4, pp. 159-162 -
Biological Prognostic Markers in Chronic Lymphocytic Leukemia
Vladimíra Vroblová, Lukáš Smolej, Filip Vrbacký, Karolína Jankovičová, Monika Hrudková, Jaroslav Malý, Jan Krejsek
2009, Vol. 52, Issue 1, pp. 3-8 -
Treatment of Multifocal Multisystem BRAF Positive Langerhans Cell Histiocytosis with Cladribine, Surgery and Allogenic Stem Cell Transplantation
Filip Gabalec, Martin Šimkovič, Alžběta Zavřelová, Petra Kašparová, Paula Morávková, Marcela Kopáčová, Václav Masopust, Pavel Žák, Jan Čáp, Jakub Radocha
2017, Vol. 60, Issue 4, pp. 152-156 -
Monoclonal Gammopathies in a Series of 1743 Plasma Donors
Vladimír Maisnar, Miloš Tichý, Vít Řeháček, Vladimír Palička, Jaroslav Malý
2006, Vol. 49, Issue 2, pp. 119-121 -
Analysis of Thrombotic Complications After Catheter Ablation
Luděk Haman, Petr Pařízek, Radovan Malý, Jiří Duda, Jaroslav Malý
2006, Vol. 49, Issue 1, pp. 47-50 -
Transplantation of Bone Marrow Derived Progenitor Cells in Acute Myocardial Infarction. The First Results
Radek Pudil, Jan Vojáček, Stanislav Filip, Pavel Měřička, Josef Šťásek, Hana Straková, Doris Vokurková, Miroslav Solař, Jaroslav Mokrý, Jan Dominik, Jaroslav Malý
2005, Vol. 48, Issue 3-4, pp. 153-155 -
Plasma Concentrations of Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor in Lymphoproliferative Disorders
Lukáš Smolej, Ctirad Andrýs, Vladimír Maisnar, Luděk Pour, Jaroslav Malý
2005, Vol. 48, Issue 1, pp. 57-58 -
The “Edge Effect” After Implantation of β-Emitting (55Co) Stents with High Initial Activity
Pavel Červinka, Josef Šťásek, Marco Aurelio Costa, Jan Štursa, Miloslav Fišer, Petr Vodňanský, Michaela Kočišová, Josef Veselka, Miloslav Pleskot, Jaroslav Malý
2004, Vol. 47, Issue 1, pp. 37-42 -
Intravascular Large B-Cell Lymphoma Presenting As Cutaneous Panniculitis
Karel Dědič, David Belada, Pavel Žák, Zdeněk Nožička
2003, Vol. 46, Issue 3, pp. 121-123 -
Minimal Residual Disease, Its Detection and Significance in Hairy-Cell Leukemia
Pavel Žák, Ladislav Chrobák, Karel Dědič
1999, Vol. 42, Issue 3, pp. 85-88 -
Red Cell Distribution Width (RDW) as a Marker of Disease Activity in Patients with Hairy Cell Leukemia
Ladislav Chrobák, Pavel Žák, Karel Podzimek, Pravoslav Stránský
1998, Vol. 41, Issue 1, pp. 23-26 -
Long-Term Results in Hairy Cell Leukemia Treated with 2-Chlorodeoxyadenosine
Ladislav Chrobák, Pavel Žák, Karel Podzimek, Lenka Plíšková, Jaroslava Foglová, Vladimír Maisnar, Petr Dulíček, Karel Dědič
1997, Vol. 40, Issue 2, pp. 41-45 -
Hirata’s Disease: Rare Cause of Hypoglycaemia in Caucasian Male
Kateřina Žibřidová, Barbora Havlínová, Eliška Svobodová, Pavel Žák, Jan Čáp, Filip Gabalec
2021, Vol. 64, Issue 1, pp. 50-54